Matthew Scarborough

Headley Way
Oxford, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 56 publications

Cefazolin for Methicillin-Susceptible Staphylococcus aureus Bacteremia.

Cefazolin for Methicillin-Susceptible Staphylococcus aureus Bacteremia.

Journal: The New England journal of medicine

Published: June 17, 2026

Corrigendum to 'Intradiscal linezolid (PP353) treatment for chronic low back pain associated with Modic change type 1: an international, first-in-human, randomised, sham procedure-controlled, double-blind, phase 1b clinical trial' eClinicalMedicine 2026; 92: 103764.

Corrigendum to 'Intradiscal linezolid (PP353) treatment for chronic low back pain associated with Modic change type 1: an international, first-in-human, randomised, sham procedure-controlled, double-blind, phase 1b clinical trial' eClinicalMedicine 2026; 92: 103764.

Journal: EClinicalMedicine

Published: March 20, 2026

Outcomes of Surgical Site Infection Following Cranial Surgery From a UK Tertiary Center.

Outcomes of Surgical Site Infection Following Cranial Surgery From a UK Tertiary Center.

Journal: Open forum infectious diseases

Published: March 05, 2026

Two-Year Outcomes of Postoperative Spine Infection: Implant Retention and Predictors of Treatment Failure.

Two-Year Outcomes of Postoperative Spine Infection: Implant Retention and Predictors of Treatment Failure.

Journal: Open forum infectious diseases

Published: February 04, 2026

Geographical Differences in the Epidemiology and Treatment of Candida Prosthetic Joint Infections.

Geographical Differences in the Epidemiology and Treatment of Candida Prosthetic Joint Infections.

Journal: Open forum infectious diseases

Published: January 31, 2026

Intradiscal linezolid (PP353) treatment for chronic low back pain associated with Modic change type 1: an international, first-in-human, randomised, sham procedure-controlled, double-blind, phase 1b clinical trial.

Intradiscal linezolid (PP353) treatment for chronic low back pain associated with Modic change type 1: an international, first-in-human, randomised, sham procedure-controlled, double-blind, phase 1b clinical trial.

Journal: EClinicalMedicine

Published: August 29, 2025

A Comparison of Causative Pathogens in Bone and Prosthetic Joint Infections: Implications for Antimicrobial Therapy.

A Comparison of Causative Pathogens in Bone and Prosthetic Joint Infections: Implications for Antimicrobial Therapy.

Journal: Antibiotics (Basel, Switzerland)

Published: October 29, 2024

Fluoroquinolones in orthopaedic infection: balancing risks and rewards.

Fluoroquinolones in orthopaedic infection: balancing risks and rewards.

Journal: The Journal of antimicrobial chemotherapy

Published: August 23, 2024

Local Antimicrobial Therapy with Combined Aminoglycoside and Vancomycin Compared to Aminoglycoside Monotherapy in the Surgical Management of Osteomyelitis and Fracture-Related Infection.

Local Antimicrobial Therapy with Combined Aminoglycoside and Vancomycin Compared to Aminoglycoside Monotherapy in the Surgical Management of Osteomyelitis and Fracture-Related Infection.

Journal: Antibiotics (Basel, Switzerland)

Published: June 27, 2024

Prosthetic Joint Infections due to Candida Species: A Multicenter International Study.

Prosthetic Joint Infections due to Candida Species: A Multicenter International Study.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: March 28, 2024

Incidence, associated disease burden and healthcare utilization due to Staphylococcus aureus prosthetic joint infection in European hospitals: the COMBACTE-NET ARTHR-IS multi-centre study.

Incidence, associated disease burden and healthcare utilization due to Staphylococcus aureus prosthetic joint infection in European hospitals: the COMBACTE-NET ARTHR-IS multi-centre study.

Journal: The Journal of hospital infection

Published: July 14, 2023

Early Oral Antibiotic Switch in Staphylococcus aureus Bacteraemia: The Staphylococcus aureus Network Adaptive Platform (SNAP) Trial Early Oral Switch Protocol.

Early Oral Antibiotic Switch in Staphylococcus aureus Bacteraemia: The Staphylococcus aureus Network Adaptive Platform (SNAP) Trial Early Oral Switch Protocol.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: June 06, 2023

Showing 1-12 of 56

Last Updated: 09/26/2026